{"schema_version":"secwatch.filing_event.v1","accession":"0001588978-26-000002","form_type":"8-K","ticker":"PRCT","cik":"0001588978","company_name":"PROCEPT BioRobotics Corp","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.557412+00:00","generated_at":"2026-05-16T00:18:25.168772+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PROCEPT BioRobotics Q4 rev $76.4M (+12% YoY), net loss $29.8M; FY26 guidance $390-410M","bullets":["Q4 total revenue $76.4M (+12% YoY); U.S. procedures ~12,200 (+69% YoY).","Q4 net loss $29.8M vs $18.9M loss; adjusted EBITDA loss $19.0M vs $10.3M.","U.S. install base 718 systems (+42% YoY); handpiece ASP $3,340 (+5% sequentially).","FY 2026 revenue guidance $390-410M (27-33% growth); U.S. procedure growth 39-48%.","FY 2026 gross margin ~65%; operating expenses ~$350M; adj. EBITDA loss $30-17M."],"urls":{"canonical":"https://secwatch.observer/filing/0001588978-26-000002","json":"https://secwatch.observer/filing/0001588978-26-000002.json","markdown":"https://secwatch.observer/filing/0001588978-26-000002.md","text":"https://secwatch.observer/filing/0001588978-26-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/0001588978-26-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/prct-20260225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:18:25.168772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}